Skip to main content
Year archive

NOXOPHARM LIMITED — 2026 filings

All 22 regulatory filings released by NOXOPHARM LIMITED (NOX) in 2026, sourced directly from the official regulator.

22 Filings
2026 Period
2026 filings (22)
Filing Released Lang
Noxopharms Sofra assets to be presented at global conference 2 pages 374.8KB
Regulatory Filings
2026-05-19 English
Proposed issue of securities - NOX 5 pages 19.0KB
Regulatory Filings
2026-05-07 English
Noxopharm progresses US regulatory strategy 3 pages 376.9KB
Regulatory Filings
2026-05-05 English
New data shows SOF-SKN active ingredient efficacy 4 pages 524.6KB
Regulatory Filings
2026-04-30 English
New Company Secretary appointed 2 pages 334.9KB
Regulatory Filings
2026-04-29 English
Innovative collaboration further expands Sofra platform 3 pages 418.4KB
Regulatory Filings
2026-04-26 English
March 2026 Quarterly Activities Report and Appendix 4C 9 pages 698.0KB
Interim / Quarterly Report Q3 2026
2026-04-23 English
Positive SOF-SKN dosing data shows prolonged skin retention 4 pages 431.7KB
Regulatory Filings
2026-04-21 English
Change of & Final Directors Interest Notice (App 3Y & 3Z)-GM 6 pages 425.2KB
Director's Dealing
2026-04-14 English
Noxopharm appoints Dr Olivier Laczka as new CEO 3 pages 331.0KB
Board/Management Information
2026-04-14 English
Resignation of Chief Executive Officer 2 pages 286.4KB
Board/Management Information
2026-04-13 English
At-the-Market (ATM) agreement with Acuity Capital 2 pages 375.4KB
Capital/Financing Update
2026-02-26 English
R&D rebate strengthens cash position 2 pages 378.0KB
Capital/Financing Update
2026-02-26 English
Application for quotation of securities - NOX 6 pages 19.2KB
Share Issue/Capital Change
2026-02-26 English
Notice under Section 708A(5)(e) of the Corps Act 2 pages 413.2KB
Share Issue/Capital Change
2026-02-26 English
Appendix 4D and FY2026 Half Year Financial Report 21 pages 854.4KB
Interim / Quarterly Report
2026-02-26 English
Sofra breakthrough science publish in major medical journal 3 pages 448.1KB
Regulatory Filings
2026-02-10 English
December 2025 Quarterly Activities Report and Appendix 4C 11 pages 620.8KB
Interim / Quarterly Report
2026-01-29 English
HERACLES clinical trial successfully completed 3 pages 285.3KB
Regulatory Filings
2026-01-20 English
Notification of cessation of securities - NOX 4 pages 14.8KB
Share Issue/Capital Change
2026-01-01 English
Notification regarding unquoted securities - NOX 7 pages 21.0KB
Capital/Financing Update
2026-01-01 English
Notice under s708A(12C)(e) of the Corporations Act 2001 13 pages 638.9KB
Capital/Financing Update
2026-01-01 English